Why GLP-1 Medications Kill Your Appetite And Why That's Actually the Point GLP-1 receptor agonists suppress appetite through two main mechanisms
Jungnik A, Arrubla Martinez J, Plum-Mrschel L, Kapitza C, Lamers D, Thamer C, et al
(PubMed) Traxer O, Huet B, Poindexter J, Pak CY, Pearle MS
FDA prescribing information, Mounjaro (tirzepatide) injection, BLA 215866: approved indications, once-weekly 2.515 mg titration, ~5-day half-life, boxed warning for thyroid C-cell tumors
When used alongside CJC 1295, the two compounds are thought to act on complementary pathways